Is Smith & Nephew plc (SNN) A Good Stock To Buy Now?
Is SNN a good stock to buy? We came across a bullish thesis on Smith & Nephew plc on r/ValueInvesting by Senior_Tadpole_3913. In this article, we will summarize the bulls’ thesis on SNN.
Smith & Nephew P L C (SNN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | LMR Partners Ben Levine, Andrew Manuel And Stefan Renold | 1,767,872 | $56,182,972 | 0.12% | |
| 2. | D E Shaw D. E. Shaw | 911,727 | $28,974,684 | +252% | 0.02% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 343,482 | $10,915,858 | -53% | 0.01% |
| 4. | Quantinno Capital Hoon Kim | 278,224 | $8,841,969 | +47% | 0.01% |
| 5. | Bridgewater Associates Ray Dalio | 275,461 | $8,754,151 | -12% | 0.04% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,241,750 | $103,022,815 | 1.17% | |
| 2. | 2,463,100 | $78,277,317 | 0.01% | |
| 3. | 2,243,019 | $71,283,144 | 0.03% | |
| 4. | 1,393,322 | $44,280,018 | 0.87% | |
| 5. | 1,385,210 | $44,022,026 | 0% |
News See All
Bernstein Cuts PT on Smith & Nephew plc (SNN)
Smith & Nephew plc (NYSE:SNN) is one of the best robotic surgery stocks to buy. Bernstein cut the price target on Smith & Nephew plc (NYSE:SNN) to $31.85 from $36.20 on May 11, maintaining a Market Perform...
7 Best Robotic Surgery Stocks to Buy
On May 20, Todd Sohn, Strategas Securities, appeared on CNBC’s ‘Power Lunch’ to discuss how investors should view the equity markets.
Canaccord Cuts PT on Smith & Nephew (SNN) Ahead of Fiscal Q1 Results
Smith & Nephew plc (NYSE:SNN) is one of the best medical device stocks to invest in right now.
10 Best Medical Device Stocks to Invest In Right Now
On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on CNBC's ‘Power Lunch’ to discuss the outlook for equity markets.
Smith & Nephew plc (NYSE:SNN) Q4 2025 Earnings Call Transcript
Deepak Nath: Good morning. Welcome to the Smith & Nephew Q4 and Full Year '25 Results Presentation. I'm Deepak Nath, I'm the Chief Executive Officer, and joining me is John Rogers, our CFO.
Jim Cramer Recently Looked at These 25 Stocks
We're in critical short supply for all sorts of chips that are needed in the data center... It wasn't easy to forecast this boom, I admit, as recently as one year ago.
RBC Capital Raises Price Target on Smith & Nephew (SNN) Ahead of Capital Markets Day
Smith & Nephew plc (NYSE:SNN), a global medical technology company based in the UK, offers a wide range of products and services within the medical equipment industry to serve its customers...
11 Best FTSE Dividend Stocks to Buy Right Now
One of the main attractions of the UK stock market is its strong dividend culture.
Moody’s Upgrades Smith & Nephew (SNN) Long-Term Rating, Citing Strong Revenue and Margin Growth
Smith & Nephew plc (NYSE:SNN) ranks among the best medical device stocks to invest in.
Hedge Fund Resource Center